AIMS: To determine if nisin F-loaded self-setting brushite cement could control the growth of Staphylococcus aureus in vivo. METHODS AND RESULTS: Brushite cement was prepared by mixing equimolar concentrations of β-tricalcium phosphate and monocalcium phosphate monohydrate. Nisin F was added at 5·0, 2·5 and 1·0% (w/w) and the cement moulded into cylinders. In vitro antibacterial activity was determined using a delayed agar diffusion assay. Release of nisin F from the cement was determined using BCA protein assays. Based on scanning electron microscopy and X-ray diffraction analysis, nisin F did not cause significant changes in cement structure or chemistry. Cement containing 5·0% (w/w) nisin F yielded the most promising in vitro results. Nisin F-loaded cement was implanted into a subcutaneous pocket on the back of mice and then infected with S. aureus Xen 36. Infection was monitored for 7 days, using an in vivo imaging system. Nisin F prevented S. aureus infection for 7 days and no viable cells were isolated from the implants. CONCLUSIONS: Nisin F-loaded brushite cement successfully prevented in vivo growth of S. aureus. SIGNIFICANCE AND IMPACT OF THE STUDY: Nisin F incorporated into bone cement may be used to control S. aureus infection in vivo.
AIMS: To determine if nisin F-loaded self-setting brushite cement could control the growth of Staphylococcus aureus in vivo. METHODS AND RESULTS:Brushite cement was prepared by mixing equimolar concentrations of β-tricalcium phosphate and monocalcium phosphate monohydrate. Nisin F was added at 5·0, 2·5 and 1·0% (w/w) and the cement moulded into cylinders. In vitro antibacterial activity was determined using a delayed agar diffusion assay. Release of nisin F from the cement was determined using BCA protein assays. Based on scanning electron microscopy and X-ray diffraction analysis, nisin F did not cause significant changes in cement structure or chemistry. Cement containing 5·0% (w/w) nisin F yielded the most promising in vitro results. Nisin F-loaded cement was implanted into a subcutaneous pocket on the back of mice and then infected with S. aureus Xen 36. Infection was monitored for 7 days, using an in vivo imaging system. Nisin F prevented S. aureus infection for 7 days and no viable cells were isolated from the implants. CONCLUSIONS:Nisin F-loaded brushite cement successfully prevented in vivo growth of S. aureus. SIGNIFICANCE AND IMPACT OF THE STUDY: Nisin F incorporated into bone cement may be used to control S. aureus infection in vivo.
Authors: Gabriel Quintana; Maria V Niederle; Carlos J Minahk; Gianluca Picariello; María E F Nader-Macías; Sergio E Pasteris Journal: World J Microbiol Biotechnol Date: 2017-09-27 Impact factor: 3.312
Authors: Michael L Chikindas; Richard Weeks; Djamel Drider; Vladimir A Chistyakov; Leon Mt Dicks Journal: Curr Opin Biotechnol Date: 2017-08-05 Impact factor: 9.740
Authors: Francisco R Fields; Giorgia Manzo; Charlotte K Hind; Jeshina Janardhanan; Ilona P Foik; Phoebe Do Carmo Silva; Rashna D Balsara; Melanie Clifford; Henry M Vu; Jessica N Ross; Veronica R Kalwajtys; Alejandro J Gonzalez; Tam T Bui; Victoria A Ploplis; Francis J Castellino; Albert Siryaporn; Mayland Chang; J Mark Sutton; A James Mason; Shaun Lee Journal: ACS Pharmacol Transl Sci Date: 2020-02-21
Authors: Linda A Jelicks; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz; Mahalia S Desruisseaux Journal: Am J Pathol Date: 2012-11-28 Impact factor: 4.307
Authors: Anton Du Preez van Staden; Tiaan Heunis; Carine Smith; Shelly Deane; Leon M T Dicks Journal: Antimicrob Agents Chemother Date: 2016-06-20 Impact factor: 5.191